CurrentCardio
Get Weekly

CurrentCardio coverage · page 12 of 17

JACC

Briefs 441–480 of 680 CurrentCardio has covered from this journal, newest publication first

Latest from JACC

All coverage, newest first

  1. J Am Coll Cardiol

    Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes

    Cohort studyCardiometabolic & kidney

  2. J Am Coll Cardiol

    Comparison of Pressure vs Volume Overload Ventricular Wall Stress in Patients With Valvular Heart Disease

    Cohort studyValvular & structural

  3. J Am Coll Cardiol

    Contemporary Pediatric Heart Transplant Waitlist Mortality

    Cohort studyHeart failure

  4. J Am Coll Cardiol

    2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures

    Guideline or statementHeart failure

  5. J Am Coll Cardiol

    Effect of Time-Varying Exposure to School-Based Health Promotion on Adiposity in Childhood

    Randomised controlled trialPrevention & lipids

  6. J Am Coll Cardiol

    Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes

    Randomised controlled trialCardiometabolic & kidney

  7. J Am Coll Cardiol

    Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report

    Cohort studyAcute care & resuscitation

  8. J Am Coll Cardiol

    Association of Adverse Clinical Outcomes With Peri-Infarct Ischemia Detected by Stress Cardiac Magnetic Imaging

    Cohort studyCoronary & ACS

  9. J Am Coll Cardiol

    Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention

    Diagnostic or prognostic studyPrevention & lipids

  10. J Am Coll Cardiol

    Mortality After Procedural or Spontaneous Myocardial Infarction

    Cohort studyCoronary & ACS

  11. J Am Coll Cardiol

    Temperature and Neurologic Outcomes in Neonates Undergoing Cardiac Surgery: A Society of Thoracic Surgeons Study

    Cohort studyCongenital

  12. J Am Coll Cardiol

    Sutureless Valves, a “Wireless” Option for Patients With Aortic Valve Disease: JACC State-of-the-Art Review

    Research articleValvular & structural

  13. J Am Coll Cardiol

    Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis

    Meta-analysisCoronary & ACS

  14. J Am Coll Cardiol

    Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs

    Secondary analysisPrevention & lipids

  15. J Am Coll Cardiol

    Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications

    Meta-analysisCoronary & ACS

  16. J Am Coll Cardiol

    Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol– or Apolipoprotein B–Related Risk of Coronary Heart Disease

    Cohort studyPrevention & lipids

  17. J Am Coll Cardiol

    10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population

    Cohort studyCoronary & ACS

  18. J Am Coll Cardiol

    Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events

    Cohort study

  19. J Am Coll Cardiol

    Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI

    Cohort studyCoronary & ACS

  20. J Am Coll Cardiol

    Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials

    Secondary analysisHeart failure

  21. J Am Coll Cardiol

    Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program

    Meta-analysisHeart failure

  22. J Am Coll Cardiol

    Adverse Cardiovascular Outcomes in Patients With Obstructive Sleep Apnea and Obesity: Metabolic Surgery vs Usual Care

    Cohort studyCardiometabolic & kidney

  23. J Am Coll Cardiol

    Impact of Social Determinants of Health on Predictive Models for Outcomes After Congenital Heart Surgery

    Cohort studyCongenital

  24. J Am Coll Cardiol

    SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy

    Cohort studyHeart failure

  25. J Am Coll Cardiol

    Excess Apolipoprotein B and Cardiovascular Risk in Women and Men

    Cohort studyPrevention & lipids

  26. J Am Coll Cardiol

    Global and Regional Cardiovascular Mortality Attributable to Nonoptimal Temperatures Over Time

    Research article

  27. J Am Coll Cardiol

    Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction

    Secondary analysis

  28. J Am Coll Cardiol

    Transcatheter Covered Stent Exclusion of Superior Sinus Venosus Defects

    Cohort studyCoronary & ACS

  29. J Am Coll Cardiol

    Clinical Risk Assessment and Prediction in Congenital Heart Disease Across the Lifespan: JACC Scientific Statement

    Guideline or statementCongenital

  30. J Am Coll Cardiol

    Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States

    Cohort studyCoronary & ACS

  31. J Am Coll Cardiol

    Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review

    Guideline or statement

  32. J Am Coll Cardiol

    Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk

    Cohort study

  33. J Am Coll Cardiol

    Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA

    Secondary analysisArrhythmias & EP

  34. J Am Coll Cardiol

    Real-World 1-Year Results of Tricuspid Edge-to-Edge Repair From the bRIGHT Study

    Cohort studyValvular & structural

  35. J Am Coll Cardiol

    Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy

    Secondary analysisHeart failure

  36. J Am Coll Cardiol

    Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease

    Secondary analysisCoronary & ACS

  37. J Am Coll Cardiol

    2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Guideline or statementAortic & peripheral

  38. J Am Coll Cardiol

    N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention

    Research articleCoronary & ACS

  39. J Am Coll Cardiol

    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus

    Cohort studyCoronary & ACS

  40. J Am Coll Cardiol

    Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults

    Cohort studyPrevention & lipids

All 680 Briefs in ExploreShowing Briefs 441–480 of 680, newest first